Clinical trial Recruiting at 1 site Observational Ages 18 and up

Examining how biological sex affects heart function in CTEPH patients

Official title: Biological Sex and Sex Hormones Moderate Right Ventricular (RV) Dysfunction and Recovery in Chronic Thromboembolic Pulmonary Hypertension

Run by Intermountain Health Care, Inc. · NCT06105242 · Data updated 2026-11-12

This study looks at how being male or female affects heart function in people with chronic thromboembolic pulmonary hypertension (CTEPH) to see if there are any differences in their recovery after surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorIntermountain Health Care, Inc.
Academic / other
Locations1 site (Murray, Utah)
StatusRecruiting
StartedMay 30, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 27, 2023
Trial IDNCT06105242 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with CTEPH who have undergone the necessary diagnostic procedures.

Probably not a fit

Patients with unclear or mixed pulmonary hypertension diagnoses, those under 18, or pregnant individuals may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify differences in right ventricular (RV) function between biological sexes in patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH). It will analyze historical data from patients who have undergone right heart catheterization and echocardiography to assess RV function at diagnosis and after pulmonary thromboendarterectomy (PTE) surgery. The study will also explore the relationship between sex hormone levels and RV function during diagnosis and recovery. The methodology includes TTE strain analysis to compare RV function across sexes.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment strategies for CTEPH based on biological sex differences.

How similar studies have gone: While studies examining sex differences in cardiovascular conditions exist, this specific focus on CTEPH and RV function recovery is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* Adult (≥18 years old) patients diagnosed with CTEPH per current guideline standard42
* Subject must have a baseline TTE (within 3 months of diagnosis) with adequate images for RVGLS analysis
* Subject must have a right heart catheterization (RHC) at the time of diagnosis
* To be included in the Aim 2 analysis, patients must undergo PTE surgery and have a TTE performed 3-9 months after surgery with adequate images for RVGLS strain analysis

Exclusion criteria

* Unclear or mixed PH diagnosis as designated by an expert clinician at Intermountain PH center
* Any subjects \<18 years of age
* Patients diagnosed during pregnancy
* Patients without a TTE and RHC at time of diagnosis

Where it's running

  • Intermountain Medical Center
    Murray, Utah, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.